Psoriasis, prostate cancer drug sales expected to soar

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.323, 2001-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug sales to soar in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Drug-Targeting Strategies for Prostate Cancer

Current Pharmaceutical Design, Vol. 9, Iss. 6, 2003-02 ,pp. : 455-466

Bentham Science Publishers

Access to resources Recommend Favorite

Prescription drug costs for the elderly soar in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 372, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Which drug combination for hormone-refractory prostate cancer?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 667-670

Informa Healthcare

Access to resources Recommend Favorite

Cabazitaxel: A Novel Drug for Hormone-Refractory Prostate Cancer

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-05 ,pp. : 915-920

Bentham Science Publishers

Access to resources Recommend Favorite